Scientific program | Satellite symposia Home > Scientific program

Breakfast Symposium - Takeda / Novartis Saturday, September 10th(​07:30-08:30​​​) – Grand Ballroom A+B+C(3F)​​
Chairperson : Hyun Jae Kang
Sang Yeol Lee
Kyung Hee University, Korea
(Takeda) The Optimized DPP4 Inhibitor in Treatment of T2DM Patients with Atherogenic Risk
Kwang Joon Kim
Yonsei University, Korea
(Novartis) DM and NAFLD – The Role of Vildagliptin

Luncheon Symposium 1- MSD Friday, September 9th(​11:50-13:20​) – ​Grand Ballroom A+B+C(3F)​
Chairperson : Bong Soo Cha
Kyung Woo Park
Seoul National University, Korea
(MSD) Beyond Statin Monotherapy : Benefit of Atozet(ezetimibe/atorvastatin) in High Risk Patients

Luncheon Symposium 2 – AstraZeneca Saturday, September 10th(​11:50-13:20​) – ​Grand Ballroom A+B+C(3F)​​
Chairperson : Hyeong Joon Yoo
Stephen Nicholls
Royal Adelaide Hospital, Australia
Triglyceride Rich Lipoproteins: The Next Frontier in Atherosclerosis?
Yong-ho Lee
Yonsei University, Korea
Benefit Your T2DM Patients by Early Initiation of Metformin/SGLT-2I Combination Treatment